Skip to content
The Policy VaultThe Policy Vault

Tyvaso — Point32Health

Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD) – WHO Group 3

Initial criteria

  • Documented diagnosis of pulmonary hypertension associated with interstitial lung disease (PH-ILD) – World Health Organization (WHO) Group 3
  • Prescribed by or in consultation with a cardiologist or pulmonologist
  • Documentation diagnosis is confirmed by right heart catheterization or pulmonary angiography